|Ms. Karen Zaderej||Chairman, Pres & CEO||1.01M||8.7M||1962|
|Mr. Peter J. Mariani||Chief Financial Officer||531.8k||N/A||1964|
|Mr. Gregory G. Freitag CPA, Esq., J.D., CPA||Gen. Counsel & Director||383.29k||2.13M||1962|
|Mr. Michael Donovan||VP of Operations||N/A||N/A||1965|
|Ms. Kaila Paige Krum||VP of Investor Relations & Corp. Devel.||N/A||N/A||N/A|
AxoGen, Inc. provides surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
AxoGen, Inc.’s ISS Governance QualityScore as of June 25, 2019 is 2. The pillar scores are Audit: 3; Board: 3; Shareholder Rights: 1; Compensation: 4.